Frontiers in Psychology (Jul 2023)
Alzheimer’s disease: a continuum with visual involvements
- Lorena Elvira-Hurtado,
- Inés López-Cuenca,
- Inés López-Cuenca,
- Rosa de Hoz,
- Rosa de Hoz,
- Rosa de Hoz,
- Mario Salas,
- Lidia Sánchez-Puebla,
- Federico Ramírez-Toraño,
- Federico Ramírez-Toraño,
- José A. Matamoros,
- José A. Fernández-Albarral,
- José A. Fernández-Albarral,
- Pilar Rojas,
- Pilar Rojas,
- Soraya Alfonsín,
- Soraya Alfonsín,
- María Luisa Delgado-Losada,
- María Luisa Delgado-Losada,
- Ana I. Ramírez,
- Ana I. Ramírez,
- Ana I. Ramírez,
- Juan J. Salazar,
- Juan J. Salazar,
- Juan J. Salazar,
- Fernando Maestu,
- Fernando Maestu,
- Fernando Maestu,
- Pedro Gil,
- Pedro Gil,
- José M. Ramírez,
- José M. Ramírez,
- José M. Ramírez,
- Elena Salobrar-García,
- Elena Salobrar-García,
- Elena Salobrar-García
Affiliations
- Lorena Elvira-Hurtado
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- Inés López-Cuenca
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- Inés López-Cuenca
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- Rosa de Hoz
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- Rosa de Hoz
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- Rosa de Hoz
- Faculty of Optics and Optometry, Department of Immunology, Ophthalmology and ENT, University of Madrid, Madrid, Spain
- Mario Salas
- Memory Unit, Geriatrics Service, Hospital Clínico San Carlos, Madrid, Spain
- Lidia Sánchez-Puebla
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- Federico Ramírez-Toraño
- Center for Cognitive and Computational Neuroscience, Laboratory of Cognitive and Computational Neuroscience, Complutense University of Madrid, Pozuelo de Alarcón, Spain
- Federico Ramírez-Toraño
- Department of Experimental Psychology, Cognitive Psychology and Speech and Language Therapy, Complutense University of Madrid, Pozuelo de Alarcón, Spain
- José A. Matamoros
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- José A. Fernández-Albarral
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- José A. Fernández-Albarral
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- Pilar Rojas
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- Pilar Rojas
- Madrid Eye Institute, Gregorio Marañón General University Hospital, Madrid, Spain
- Soraya Alfonsín
- Center for Cognitive and Computational Neuroscience, Laboratory of Cognitive and Computational Neuroscience, Complutense University of Madrid, Pozuelo de Alarcón, Spain
- Soraya Alfonsín
- Department of Experimental Psychology, Cognitive Psychology and Speech and Language Therapy, Complutense University of Madrid, Pozuelo de Alarcón, Spain
- María Luisa Delgado-Losada
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- María Luisa Delgado-Losada
- Department of Experimental Psychology, Cognitive Psychology and Speech and Language Therapy, Complutense University of Madrid, Pozuelo de Alarcón, Spain
- Ana I. Ramírez
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- Ana I. Ramírez
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- Ana I. Ramírez
- Faculty of Optics and Optometry, Department of Immunology, Ophthalmology and ENT, University of Madrid, Madrid, Spain
- Juan J. Salazar
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- Juan J. Salazar
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- Juan J. Salazar
- Faculty of Optics and Optometry, Department of Immunology, Ophthalmology and ENT, University of Madrid, Madrid, Spain
- Fernando Maestu
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- Fernando Maestu
- Center for Cognitive and Computational Neuroscience, Laboratory of Cognitive and Computational Neuroscience, Complutense University of Madrid, Pozuelo de Alarcón, Spain
- Fernando Maestu
- Department of Experimental Psychology, Cognitive Psychology and Speech and Language Therapy, Complutense University of Madrid, Pozuelo de Alarcón, Spain
- Pedro Gil
- Memory Unit, Geriatrics Service, Hospital Clínico San Carlos, Madrid, Spain
- Pedro Gil
- Department of Medicine, School of Medicine, Complutense University of Madrid, Madrid, Spain
- José M. Ramírez
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- José M. Ramírez
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- José M. Ramírez
- Faculty of Medicine, Department of Immunology, Ophthalmology and ENT, University of Madrid, Madrid, Spain
- Elena Salobrar-García
- Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, Spain
- Elena Salobrar-García
- Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain
- Elena Salobrar-García
- Faculty of Optics and Optometry, Department of Immunology, Ophthalmology and ENT, University of Madrid, Madrid, Spain
- DOI
- https://doi.org/10.3389/fpsyg.2023.1124830
- Journal volume & issue
-
Vol. 14
Abstract
IntroductionAlzheimer’s disease (AD) is the most common form of dementia affecting the central nervous system, and alteration of several visual structures has been reported. Structural retinal changes are usually accompanied by changes in visual function in this disease. The aim of this study was to analyse the differences in visual function at different stages of the pathology (family history group (FH+), mild cognitive impairment (MCI), mild AD and moderate AD) in comparison with a control group of subjects with no cognitive decline and no family history of AD.MethodsWe included 53 controls, 13 subjects with FH+, 23 patients with MCI, 25 patients with mild AD and, 21 patients with moderate AD. All were ophthalmologically healthy. Visual acuity (VA), contrast sensitivity (CS), colour perception, visual integration, and fundus examination were performed.ResultsThe analysis showed a statistically significant decrease in VA, CS and visual integration score between the MCI, mild AD and moderate AD groups compared to the control group. In the CS higher frequencies and in the colour perception test (total errors number), statistically significant differences were also observed in the MCI, mild AD and moderate AD groups with respect to the FH+ group and also between the control and AD groups. The FH+ group showed no statistically significant difference in visual functions compared to the control group. All the test correlated with the Mini Mental State Examination score and showed good predictive value when memory decline was present, with better values when AD was at a more advanced stage.ConclusionAlterations in visual function appear in subjects with MCI and evolve when AD is established, being stable in the initial stages of the disease (mild AD and moderate AD). Therefore, visual psychophysical tests are a useful, simple and complementary tool to neuropsychological tests to facilitate diagnosis in the preclinical and early stages of AD.
Keywords
- Alzheimer’s disease
- mild cognitive impairment
- family history
- visual function
- visual acuity
- contrast sensitivity